Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Gorrell

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Hepatology (Baltimore, Md.)|May 29, 1999
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosisM T Levy, G W McCaughan, C A Abbott, et al.
Scandinavian Journal of Immunology|January 5, 2011
Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase bindingD M T Yu, L Slaitini, V Gysbers, et al.
Immunological Reviews|May 12, 2000
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant toleranceG W McCaughan, M D Gorrell, G A Bishop, et al.
Diabetes Research and Clinical Practice|April 4, 2015
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesityK H Williams, A J Viera de Ribeiro, E Prakoso, et al.
Mucosal Immunology|August 22, 2020
Animal and translational models of SARS-CoV-2 infection and COVID-19M D Johansen, A Irving, X Montagutelli, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Hepatology (Baltimore, Md.)|May 29, 1999
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosisM T Levy, G W McCaughan, C A Abbott, et al.
Scandinavian Journal of Immunology|January 5, 2011
Soluble CD26 / dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase bindingD M T Yu, L Slaitini, V Gysbers, et al.
Immunological Reviews|May 12, 2000
Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant toleranceG W McCaughan, M D Gorrell, G A Bishop, et al.
Diabetes Research and Clinical Practice|April 4, 2015
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesityK H Williams, A J Viera de Ribeiro, E Prakoso, et al.
Mucosal Immunology|August 22, 2020
Animal and translational models of SARS-CoV-2 infection and COVID-19M D Johansen, A Irving, X Montagutelli, et al.
Pageof 4